CG Oncology Files Form 4 for Ownership Changes
Ticker: CGON · Form: 4 · Filed: Apr 16, 2026
Sentiment: neutral
Topics: insider-filing, ownership-change
TL;DR
CG Oncology insider James M. Detore made ownership changes. Details in Form 4.
AI Summary
On April 16, 2026, CG Oncology, Inc. filed a Form 4, reporting changes in beneficial ownership of securities. The filing details transactions by James M. Detore, a reporting person associated with the company. Specific details of the transactions, including the number of shares and dollar amounts, are not provided in this excerpt.
Why It Matters
Form 4 filings are crucial for investors as they disclose changes in stock ownership by company insiders, which can signal their confidence or concerns about the company's future.
Risk Assessment
Risk Level: low — This filing is a standard disclosure of ownership changes by an insider and does not inherently indicate positive or negative news about the company's operations or financial health.
Key Players & Entities
- CG Oncology, Inc. (company) — Issuer
- James M. Detore (person) — Reporting Person
- 0001991792 (company) — CIK for CG Oncology, Inc.
- 0001623981 (person) — CIK for James M. Detore
FAQ
What is the filing date of this Form 4?
The filing date is April 16, 2026.
Who is the reporting person mentioned in the filing?
The reporting person is James M. Detore.
What is the CIK for CG Oncology, Inc.?
The CIK for CG Oncology, Inc. is 0001991792.
What is the business address of CG Oncology, Inc.?
The business address of CG Oncology, Inc. is 3000 PEGASUS PARK DRIVE SUITE 1640 DALLAS TX 75247.
What is the period of report for this filing?
The period of report is 2026-04-15.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 16, 2026 by James M. Detore regarding CG Oncology, Inc. (CGON). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.